Gilead Sciences has outperformed the broader market over the past year, and analysts are moderately optimistic about the ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...